Shares of Strides Pharma Science Ltd fell as much as 5.34 per cent to 472.40, their lowest since August 24 on USFDA observations.
The company said that the USFDA has issued Form 483 with three observations after inspecting its Bengaluru facility. The company believes that the observations are not material in nature.
The stock posted biggest intraday fall since July 16. As of last close, the stock had fallen 37.5 per cent this year.